These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12723850)

  • 21. A five year follow-up study of the use of clozapine in community practice.
    Drew LR; Griffiths KM; Hodgson DM
    Aust N Z J Psychiatry; 2002 Dec; 36(6):780-6. PubMed ID: 12406120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and economic outcomes associated with olanzapine for the treatment of psychotic symptoms in a county mental health population.
    Del Paggio D; Finley PR; Cavano JM
    Clin Ther; 2002 May; 24(5):803-17. PubMed ID: 12075948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
    Moisan J; Grégoire JP
    Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective study of psychotropic drug use among individuals with mental illness issued a community treatment order.
    Gisev N; Bell JS; Chen TF
    Int J Clin Pract; 2014 Feb; 68(2):236-44. PubMed ID: 24372715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insurance coverage and the treatment of mental illness: effect on medication and provider use.
    Mulvale G; Hurley J
    J Ment Health Policy Econ; 2008 Dec; 11(4):177-99. PubMed ID: 19096092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment.
    Swanson JW; Swartz MS; Elbogen EB
    Schizophr Bull; 2004; 30(1):3-20. PubMed ID: 15176758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Audit of antipsychotic prescribing in a private psychiatric hospital.
    Botvinik L; Ng C; Schweitzer I
    Australas Psychiatry; 2004 Sep; 12(3):227-33. PubMed ID: 15715780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical antipsychotic use in a state hospital inpatient adolescent population.
    Kelly DL; Love RC; MacKowick M; McMahon RP; Conley RR
    J Child Adolesc Psychopharmacol; 2004; 14(1):75-85. PubMed ID: 15142394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes Screening Among Underserved Adults With Severe Mental Illness Who Take Antipsychotic Medications.
    Mangurian C; Newcomer JW; Vittinghoff E; Creasman JM; Knapp P; Fuentes-Afflick E; Schillinger D
    JAMA Intern Med; 2015 Dec; 175(12):1977-9. PubMed ID: 26551047
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolic Side Effects in Patients Using Atypical Antipsychotic Medications During Hospitalization.
    Dikeç G; Arabaci LB; Uzunoglu GB; Mizrak SD
    J Psychosoc Nurs Ment Health Serv; 2018 Apr; 56(4):28-37. PubMed ID: 29328360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization.
    Jiang Y; Ni W
    Pharmacotherapy; 2015 Sep; 35(9):813-22. PubMed ID: 26406773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population.
    Eaddy M; Grogg A; Locklear J
    Clin Ther; 2005 Feb; 27(2):263-72. PubMed ID: 15811492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of public mental health services in a random community sample.
    Short T; Thomas S; Luebbers S; Ogloff JR; Mullen P
    Aust N Z J Psychiatry; 2010 May; 44(5):475-81. PubMed ID: 20397791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of atypical versus typical antipsychotic medication on earnings of schizophrenia patients : estimates from a prospective naturalistic study.
    Salkever D; Slade E; Karakus M
    Pharmacoeconomics; 2006; 24(2):123-39. PubMed ID: 16460134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease.
    Edell WS; Rupnow MF
    Manag Care Interface; 2003 May; 16(5):64-7. PubMed ID: 12789866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship Between Antipsychotic Medications and Cerebrovascular Disease in Patients With Serious Mental Illness.
    Berrocal-Izquierdo N; Bioque M; Bernardo M
    J Psychiatr Pract; 2018 Mar; 24(2):72-78. PubMed ID: 29509176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia.
    Joshi K; Mao L; Biondi DM; Millet R
    BMC Psychiatry; 2018 Jan; 18(1):24. PubMed ID: 29378547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-year outcome of phase-specific early intervention for first-episode psychosis: a cohort study in Hong Kong.
    Chen EY; Tang JY; Hui CL; Chan SK; Chang WC; Lee EH; Chiu CP; Lam MM; Law CW; Yew CW; Wong GH; Chung DW; Tso S; Chan KP; Yip KC; Fung SF; Honer WG
    Hong Kong Med J; 2012 Dec; 18 Suppl 6():7-13. PubMed ID: 23249845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.